Antibiotice Iasi has reported a net business turnover for the first nine months of 2021 of 247.83 million lei, up 21% y-o-y, according to data submitted on Wednesday to the Bucharest Stock Exchange (BVB).The company says it is a world leader in the production of the active substance nystatin covering 55% of the international market.The value of its gross profit at the end of September was 18.68 million lei, at the same level as in the same period of 2020.In the first nine months of 2021, the value of medicines dispensed to patients in Romania was 15.3 billion lei (in distribution prices), up 18% from the same period of 2020.The value of its export of finished products was 60.02 million lei, as projected in terms of value and profit margin.Production churned out 244.7 million pharmaceutical items in the form of tablets, capsules, parenteral products, topical products (ointments, creams, gels), suppositories, ovules, biocidal products, by all three of its production divisions. In terms of value, the total production for the first nine months is 239.9 million lei.The investment planned for 2021 is worth 93.52 million lei, approved by the General Meeting of Shareholders on April 21, 43.02 million lei of which was budgeted for the first nine months, and 32.51 million lei actually invested as of September 30, 2021.Antibiotice S.A. started up in 1955 as the first producer of the active substance penicillin in Romania and South-Eastern Europe. It is currently the most important Romanian producer of generic drugs.Antibiotice's product portfolio includes over 150 medicines for human use in 11 therapeutic areas, veterinary medicines, the active substance nystatin, and biocidal products.Antibiotice Iasi has been floated on the Premium tier of the Bucharest Stock Exchange since 1997. The market capitalisation of Antibiotice as of September 30, 2021 was 381.32 million lei.
June is the richest month. The most awaited two weeks in my annual festival pilgrimage. The route starts with Romania’s Transilvania International Film Festival (TIFF), followed by Italy’s (and the world’s) most comprehensive festival for restored and archival film: Il Cinema Ritrovato. To shake up the traditional article on the two, I’ll start with the […]
Different Beauty, a recently opened exhibition of works by Czech photographer David Těšínský, offers a glimpse into everyday life in the war-torn region of Donbas in 2017. The photos were taken within the span of only a few days, as Těšínský traveled to eastern Ukraine to document the lives of women impacted by war. In […]
Different Beauty, a recently opened exhibition of works by Czech photographer David Těšínský, offers a glimpse into everyday life in the war-torn region of Donbas in 2017. The photos were taken within the span of only a few days, as Těšínský traveled to eastern Ukraine to document the lives of women impacted by war. In […]
Roughly 70% of Romanians are “very” or “moderately” concerned about how AI accesses and uses their data, according to the latest survey conducted by RoCoach in partnership with Novel Research between May and June 2025. Distrust in automated decision-making and the demand for regulation are becoming more pronounced, as Romania rolls out major digitalization projects […]
The Armenian Street Festival returns for a 9th edition between August 1 and 3, 2025, in the “Dimitrie Brândză” Botanical Garden in Bucharest. The festival brings into focus the living heritage of the Armenian community in Romania and the diaspora. According to the organizers, this year’s edition aims to strengthen the Bucharest–Chișinău–Yerevan cultural axis, articulated […]
The Romanian mergers and acquisitions market registered a total of 122 announced transactions in the first half of 2025, with a value exceeding EUR 2.7 billion, marking a slight increase of 6% in volume and 4% in value compared to the same period last year, according to an analysis by George Ureche, partner at PwC Romania. […]
